miR-19b represses CYLD expression and upregulates NFKB expression to active NF-KB pathway in T-ALL, and TCF3 regulates miR-125b and MYC in AML pathways [17, 18]. Here, NFKB1 is linked to acute lymphoblastic leukemia.